Amblyopia is reduced vision arising during childhood development. It may be present even when a child’s eyes look straight and healthy.

What is amblyopia?
Amblyopia, sometimes called lazy eye, develops when the brain does not learn to see clearly with one eye, or less commonly both eyes, during childhood. A child may rely on the better-seeing eye without noticing a problem. The word “lazy” does not describe the child’s effort or behaviour. Early detection gives treatment the best opportunity to help. NEI overview
Signs and when to arrange assessment
There may be no obvious outward sign. Some children tilt their head, close an eye, squint or have difficulty judging depth. Routine vision screening is important because a child can manage daily activities despite reduced vision in one eye. Arrange assessment when screening raises a concern or you notice a persistent difference in how the eyes work. NEI
A sudden loss or change of vision, a painful red eye or a newly developed eye turn needs prompt assessment for other causes. Sudden loss of vision requires emergency care. Amblyopia should not be used to explain a new acute symptom. NHS red-eye guidance | NHS squint guidance
Causes and risk factors
A large difference in glasses prescription between the eyes, substantial uncorrected focusing error or strabismus can interrupt visual development. A cataract, drooping eyelid or other obstruction can also limit a child’s visual input and may require early specialist care. Amblyopia can occur while the eyes appear normal. AAPOS explanation
How is it diagnosed?
Assessment checks vision in each eye using age-appropriate methods, eye alignment and eye health. Drops may help the clinician measure focusing needs and examine the eye. An examination identifies the cause and helps distinguish amblyopia from another reason for reduced vision. NHS assessment
General treatment options
Glasses are often the first step. Some children also need prescribed patching or drops that temporarily reduce the stronger eye’s advantage, encouraging use of the weaker eye. Surgery may address an underlying cataract, drooping lid or misalignment, but additional amblyopia treatment can still be necessary. The clinician sets the plan and monitors both eyes. AAPOS treatment information
Bring up difficulties with glasses, patches or drops early. Treatment can take months, and follow-up is needed to assess improvement and recurrence. Do not start patching, change which eye is covered or alter the schedule yourself. NEI | AAPOS
A useful study: individualising patching
A 2003 PEDIG randomised trial compared shorter and longer daily patching regimens in children younger than seven with moderate amblyopia. Average improvement at four months was similar between groups. This supports avoiding a one-size-fits-all approach. The result does not set a schedule for every child or for severe amblyopia; the treating clinician should prescribe and review it. Original PEDIG study
Amblyopia: Supporting Vision Development in Children illustrated

Questions for your child’s appointment
- What caused the reduced vision, and what is the goal of treatment?
- Are glasses alone the first step?
- How can we make treatment manageable at home and school?
- When will both eyes be checked again?
Frequently asked questions
Is amblyopia the same as strabismus?
No. Amblyopia concerns visual development; strabismus means eye misalignment. They can occur together. AAPOS
Is it too late for an older child?
Some older children benefit. Ask for an assessment rather than assuming age alone rules treatment out. AAPOS
Will straightening an eye cure amblyopia?
Alignment surgery may be part of care, but it does not replace vision-development treatment. NHS
This page is educational; a child’s treatment requires individual supervision.
Sources and further reading
- National Eye Institute: Amblyopia
- NHS: Lazy eye
- AAPOS: Amblyopia
- Repka et al., PEDIG, 2003: A randomized trial of patching regimens for treatment of moderate amblyopia in children
- NHS: Red eye
- NHS: Squint
General educational information prepared October 2026. Treatments described are general options; availability and suitability require an individual assessment.
